AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Comet Resources Ltd

0.200

0.000

Volume:- -

Turnover:- -

Market Cap:13.83M

PE:-6.78

High:0.200

Open:0.200

Low:0.200

Close:0.200

52wk High:0.200

52wk Low:0.200

Shares:69.16M

Float Shares:26.19M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.030

EPS(LYR):-0.030

ROE:-53.62%

ROA:-16.18%

PB:4.73

PE(LYR):-6.78

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

A Look At Charles River Laboratories (CRL) Valuation After Recent Share Price Momentum

Simply Wall St.

Why Charles River (CRL) Is Up 9.1% After Naming Long‑Time Insider Birgit Girshick CEO

Simply Wall St.

Did Lower Guidance and Weak Earnings Just Shift Charles River Laboratories' (CRL) Investment Narrative?

Simply Wall St.

A Fresh Look at Charles River Laboratories (CRL) Valuation Following Recent Share Price Momentum

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CRL.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"CRL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CRL.AU\",,,,,undefined,":{"symbol":"CRL.AU","market":"AU","secType":"STK","nameCN":"Comet Resources Ltd","latestPrice":0.2,"timestamp":1770354000000,"preClose":0.2,"halted":9,"volume":0,"delay":0,"changeRate":0,"nameEN":"Comet Resources Ltd","floatShares":26192756,"shares":69159244,"eps":-0.029502,"marketStatus":"Market Closed","change":0,"latestTime":"02-06 16:00:00 AEDT","open":0.2,"high":0.2,"low":0.2,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.029502,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770591600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.2,"openAndCloseTimeList":[[1770332400000,1770354000000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CRL.AU\",,,,,undefined,":{"symbol":"CRL.AU","floatShares":26192756,"roa":"-16.18%","roe":"-53.62%","lyrEps":-0.029502,"shares":69159244,"dividePrice":0,"high":0.2,"amplitude":0,"preClose":0.2,"low":0.2,"week52Low":0.2,"pbRate":"4.73","week52High":0.2,"institutionHeld":0,"latestPrice":0.2,"eps":-0.029502,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.029502,"open":0.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-01-31","symbol":"CRL.AU","reason":null,"defaultRemindTime":1706655600000,"announcedDate":"2024-01-30","type":"delisting","dateTimestamp":1706619600000},{"market":"AU","date":"2022-11-14","symbol":"CRL.AU","defaultRemindTime":1668380400000,"type":"split","dateTimestamp":1668344400000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"AU","date":"2022-07-20","symbol":"CRL.AU","defaultRemindTime":1658275200000,"type":"split","dateTimestamp":1658239200000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRL.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2605476802","title":"A Look At Charles River Laboratories (CRL) Valuation After Recent Share Price Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2605476802","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605476802?lang=en_us&edition=fundamental","pubTime":"2026-01-23 14:52","pubTimestamp":1769151141,"startTime":"0","endTime":"0","summary":"Recent performance snapshot and what it might mean for investors\nCharles River Laboratories International (CRL) has drawn investor attention after recent trading, with the stock closing at $224.03 and showing mixed short term moves alongside stronger returns over the past year.\nOver the past month, the stock return is 10.43%. The past 3 months show a 13.70% gain, and the 1 year total return stands at 34.26%. Short term performance is more muted, with a 0.25% move over the past week and a...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-crl/charles-river-laboratories-international/news/a-look-at-charles-river-laboratories-crl-valuation-after-rec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-crl/charles-river-laboratories-international/news/a-look-at-charles-river-laboratories-crl-valuation-after-rec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4530","LU1815336091.USD","LU0390134368.USD","CRL.AU","BK7095","BK4585","BK4588","LU0029874061.USD","BK4121","LU0128526141.USD","IE00BFMHRM44.USD","CRL","LU0757428866.USD"],"gpt_icon":0},{"id":"2602351552","title":"Why Charles River (CRL) Is Up 9.1% After Naming Long‑Time Insider Birgit Girshick CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2602351552","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602351552?lang=en_us&edition=fundamental","pubTime":"2026-01-11 22:14","pubTimestamp":1768140871,"startTime":"0","endTime":"0","summary":"Charles River Laboratories International announced that long‑time Chair, President and CEO James C. Foster will retire in May 2026, with current Chief Operating Officer Birgit Girshick appointed as his successor and nominated to join the Board, while Foster remains as a non‑executive Director and the Chair and CEO roles are separated.\nThis transition caps Foster’s 50‑year tenure in which Charles River evolved from a niche research models business into a global preclinical contract research...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-crl/charles-river-laboratories-international/news/why-charles-river-crl-is-up-91-after-naming-longtime-insider","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-crl/charles-river-laboratories-international/news/why-charles-river-crl-is-up-91-after-naming-longtime-insider","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CRL","LU0128526141.USD","LU1815336091.USD","BK4530","IE00BFMHRM44.USD","LU0390134368.USD","LU0757428866.USD","LU0029874061.USD","BK7095","BK4585","BK4588","BK4121","CRL.AU"],"gpt_icon":0},{"id":"2583310595","title":"Did Lower Guidance and Weak Earnings Just Shift Charles River Laboratories' (CRL) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2583310595","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583310595?lang=en_us&edition=fundamental","pubTime":"2025-11-13 10:17","pubTimestamp":1763000224,"startTime":"0","endTime":"0","summary":"On November 5, 2025, Charles River Laboratories International reported a year-over-year decrease in revenue and net income for the third quarter, alongside lowering its full-year outlook for revenue growth and earnings per share.\nDespite announcing a new US$1.0 billion share repurchase program, the company reported no new share buybacks in the most recent quarter as operational performance softened.\nWe will explore how the reduced full-year guidance and weaker quarterly earnings reshape...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-crl/charles-river-laboratories-international/news/did-lower-guidance-and-weak-earnings-just-shift-charles-rive","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-crl/charles-river-laboratories-international/news/did-lower-guidance-and-weak-earnings-just-shift-charles-rive","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CRL","CRL.AU"],"gpt_icon":0},{"id":"2577680363","title":"A Fresh Look at Charles River Laboratories (CRL) Valuation Following Recent Share Price Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2577680363","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577680363?lang=en_us&edition=fundamental","pubTime":"2025-10-22 17:29","pubTimestamp":1761125345,"startTime":"0","endTime":"0","summary":"Charles River Laboratories International (CRL) stock has shown steady gains over the past month, returning 21%. Investors are watching recent momentum as the company posts annual revenue and net income growth in its latest financial update.\nSee our latest analysis for Charles River Laboratories International.\nThe recent momentum in Charles River Laboratories International’s shares has grabbed attention, with a 1-month share price return of 21.2% and a solid 7-day gain that signals renewed...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-crl/charles-river-laboratories-international/news/a-fresh-look-at-charles-river-laboratories-crl-valuation-fol","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-crl/charles-river-laboratories-international/news/a-fresh-look-at-charles-river-laboratories-crl-valuation-fol","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","IE00BFMHRM44.USD","LU1815336091.USD","LU0390134368.USD","BK4121","BK4530","LU0757428866.USD","BK7095","CRL","CRL.AU","BK4585"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CRL.AU\",params:#limit:6,delay:true,,,undefined,":[]}}